Main clinical features of COVID-19 and potential prognostic and therapeutic value of the microbiota in SARS-CoV-2 infections
Y He, J Wang, F Li, Y Shi - Frontiers in Microbiology, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
(SARS) coronavirus 2 (SARS-CoV-2), has become a pandemic, infecting more than …
(SARS) coronavirus 2 (SARS-CoV-2), has become a pandemic, infecting more than …
Microbiota and COVID-19: Long-term and complex influencing factors
J Gang, H Wang, X Xue, S Zhang - Frontiers in Microbiology, 2022 - frontiersin.org
The coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). According to the World Health …
respiratory syndrome coronavirus 2 (SARS-CoV-2). According to the World Health …
Is a healthy microbiome responsible for lower mortality in COVID-19?
L Janda, M Mihalčin, M Šťastná - Biologia, 2021 - Springer
The novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is the cause of
an ongoing pandemic with significant case fatality ratio (CFR) worldwide. Although SARS …
an ongoing pandemic with significant case fatality ratio (CFR) worldwide. Although SARS …
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions
The global coronavirus disease 2019 (COVID-19) pandemic is currently ongoing. It is
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A high …
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A high …
Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
The gastrointestinal tract is involved in coronavirus disease 2019 (COVID-19) caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The gut microbiota has …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The gut microbiota has …
Is gut microbiota dysbiosis a predictor of increased susceptibility to poor outcome of COVID-19 patients? An update
The scientific knowledge already attained regarding the way severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infects human cells and the clinical manifestations …
syndrome coronavirus 2 (SARS-CoV-2) infects human cells and the clinical manifestations …
The role of bacterial and fungal human respiratory microbiota in COVID‐19 patients
Recently, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the etiologic
agent of coronavirus disease 2019 (COVID‐19), has led to a worldwide pandemic with …
agent of coronavirus disease 2019 (COVID‐19), has led to a worldwide pandemic with …
Diagnostic, prognostic, and therapeutic roles of gut microbiota in COVID-19: a comprehensive systematic review
Introduction The Coronavirus Disease 2019 (COVID-19) pandemic caused by Severe Acute
Respiratory Coronavirus 2 (SARS-CoV-2) emerged in late December 2019. Considering the …
Respiratory Coronavirus 2 (SARS-CoV-2) emerged in late December 2019. Considering the …
Gut microbiota diversity and C-reactive protein are predictors of disease severity in COVID-19 patients
A Moreira-Rosário, C Marques, H Pinheiro… - Frontiers in …, 2021 - frontiersin.org
The risk factors for coronavirus disease 2019 (COVID-19) severity are still poorly
understood. Considering the pivotal role of the gut microbiota on host immune and …
understood. Considering the pivotal role of the gut microbiota on host immune and …
Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection
K Krasaewes, R Chaiwarith, N Chattipakorn… - Life Sciences, 2023 - Elsevier
The correlation between SARS-CoV-2 infection and gut microbiota has been a subject of
growing interest in recent research endeavors. It is postulated that SARS-CoV-2 might lead …
growing interest in recent research endeavors. It is postulated that SARS-CoV-2 might lead …
相关搜索
- sars cov covid 19
- therapeutic value covid 19
- covid 19 patients
- long term covid 19
- alterations in microbiota covid 19
- clinical applications covid 19
- therapeutic interventions covid 19
- lower mortality in covid 19
- healthy microbiome covid 19
- unrecognized player covid 19
- sars cov therapeutic value
- sars cov clinical outcomes
- therapeutic interventions microbiota of patients
- therapeutic interventions alterations in microbiota